Skip to main content
Clinical Trials/NCT05171426
NCT05171426
Completed
Not Applicable

Incidental Cancer in Colectomy Specimens From Patients With Familial Adenomatous Polyposis

Dr. Ersin Arslan Education and Training Hospital1 site in 1 country55 target enrollmentStarted: January 1, 2018Last updated:
ConditionsCancer

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Dr. Ersin Arslan Education and Training Hospital
Enrollment
55
Locations
1
Primary Endpoint
incidental cancer

Overview

Brief Summary

Colectomy is life-saving in patients with familial adenomatous polyposis (FAP) because cancer development is inevitable in individuals with this disease. In this study, we aimed to determine the incidence of incidental malignancy in surgical specimens from patients who underwent colectomy for FAP. Prophylactic colectomy should be performed in patients with FAP, as colorectal cancer transformation is inevitable in these individuals. The possibility of incidental cancer identified via histopathological analysis of colectomy specimens should be kept in mind in these patients.

Detailed Description

Colectomy is life-saving in patients with familial adenomatous polyposis (FAP) because cancer development is inevitable in individuals with this disease. In this study, we aimed to determine the incidence of incidental malignancy in surgical specimens from patients who underwent colectomy for FAP. The files of patients diagnosed with FAP who underwent surgery in our clinic between 2010 and 2020 were retrospectively reviewed. Definitive surgery was performed in patients with histopathological malignancy identified in colonoscopic biopsies in the preoperative period, while prophylactic surgery was performed in patients without malignancy. The incidence of incidental malignancy in histopathological specimens from patients who underwent prophylactic colectomy was determined. Prophylactic colectomy should be performed in patients with FAP, as colorectal cancer transformation is inevitable in these individuals. The possibility of incidental cancer identified via histopathological analysis of colectomy specimens should be kept in mind in these patients.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • diagnosed with Familial Adenomatous Polyposis

Exclusion Criteria

  • did not receive surgical treatment
  • data deficiencies

Outcomes

Primary Outcomes

incidental cancer

Time Frame: 2 or 3 week

Familial Adenomatous Polyposis with cancer

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Dr. Ersin Arslan Education and Training Hospital
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Ufuk Uylas

Primary investigator

Tepecik Training and Research Hospital

Study Sites (1)

Loading locations...

Similar Trials